EOSINOPHILIC MYELOID NEOPLASM

Clinical trials for EOSINOPHILIC MYELOID NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new EOSINOPHILIC MYELOID NEOPLASM trials appear

Sign up with your email to follow new studies for EOSINOPHILIC MYELOID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Cancer drug trial offers hope for rare blood disease

Disease control Ongoing

This study is testing whether a drug called imatinib (Gleevec®), which is used for some cancers, can safely and effectively lower dangerously high levels of a specific white blood cell (eosinophils) in people with hypereosinophilic syndrome (HES). HES is a rare condition where to…

Matched conditions: EOSINOPHILIC MYELOID NEOPLASM

Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

EOSINOPHILIC MYELOID NEOPLASM

Get alerted when new EOSINOPHILIC MYELOID NEOPLASM trials appear

Cancer drug trial offers hope for rare blood disease